Our commitment to quality excellence has been evidenced externally over the years not only through the quality of our products, but also through the work of our member companies on our internal and external endeavors such as; continuous learning and improvement, engagement in public policy, scientific and educational forums with regulators, academia and industry colleagues, and ongoing input into regulatory and technical dialogues and processes with regulators and other segments of industry – i.e., active pharmaceutical ingredient manufacturers, packaging and labeling companies, etc. We urge industry associations from the brand and biotech pharmaceutical sectors to follow our lead by joining this commitment to quality excellence by developing and publishing their own position paper. Our patients count on all of us to promote and protect their health, and we must take all necessary steps to document and effectuate this responsibility.

We at adduco harbor a high degree of social responsibility through our products (medicines) that are made available to the general public. Access to these products can make the difference between life and death.